Clinical trial · Observational
Diagnostic Classifier for Cutaneous T-cell Lymphomas
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Primary cutaneous T-cell lymphomas (CTCL) are a form of skin cancer that is derived from immune cells. The most common form of CTCL is mycosis fungoides (MF). While initially confined to the skin, MF may spread to lymph nodes, blood or inner organs, resulting in an overall poor prognosis for the patient. Thus, being a potentially lethal disease, an early and correct diagnosis of MF has very important implications for the patient. However, diagnosis of early MF is often difficult, as it usually shows a close resemblance to benign inflammatory conditions such as eczema and psoriasis. Strikingly, it takes an average of 3-6 (!) years from the appearance of the first skin lesions until a diagnosis of MF can be made. For this reason, a test to distinguishing early MF from benign inflammatory conditions is urgently mandated. By using skin suction blister fluid as well as skin biopsies from patients with MF, eczema and psoriasis, the investigators want to develop a classifier system that can distinguish early MF from benign inflammatory skin diseases.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| CTCL/ Mycosis Fungoides | Mycosis Fungoides | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Skin suction blistering and skin biopsies | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- label
- Mycosis fungoides (MF)
- interventionNames
- Diagnostic Test: Skin suction blistering and skin biopsies
- label
- Eczema (Atopic Dermatitis)
- interventionNames
- Diagnostic Test: Skin suction blistering and skin biopsies
- label
- Chronic Plaque-Psoriasis
- interventionNames
- Diagnostic Test: Skin suction blistering and skin biopsies
- label
- Healthy Control Skin
- interventionNames
- Diagnostic Test: Skin suction blistering and skin biopsies
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 100 Years
Show eligibility criteria text
Inclusion Criteria: * Clinical and/or histopathological diagnosis of MF, eczema or psoriasis * Healthy control subjects without personal history of MF, eczema or psoriasis Exclusion Criteria: * Ongoing skin-targeted treatment (Wash out times: 2 weeks for topical, and 4 weeks for systemic treatments) * Ongoing other treatment that might, in the opinion of the investigator, influence proteomic features of the samples to be acquired
References
Publications (0)
Data not yet available